(Q43030811)

12 November 2017

The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study (English)

1 reference

mild cognitive impairment

12 November 2017

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

3

Nancy Paquet

1 reference

12 November 2017

Robert Laforce

1

1 reference

12 November 2017

James P Buteau

2

1 reference

12 November 2017

Louis Verret

4

1 reference

12 November 2017

Michèle Houde

5

1 reference

12 November 2017

Rémi W Bouchard

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

American Journal of Alzheimer's Disease & Other Dementias

12 November 2017

1 reference

12 November 2017

25

1 reference

12 November 2017

4

1 reference

12 November 2017

324-332

1 reference

Positron emission tomography imaging in dementia.

12 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Emission tomography in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Accuracy of the clinical evaluation for frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Early detection of Alzheimer's disease using neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Added Clinical Benefit of Incorporating 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

The value of positron emission tomography in the clinical evaluation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Diagnosis and treatment of dementia: 2. Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

The role of neuroimaging in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

21 January 2018

Neuroimaging in Dementia

1 reference

https://api.crossref.org/works/10.1177%2F1533317510363468

21 January 2018

Identifiers

DOI

10.1177/1533317510363468

1 reference

12 November 2017

1 reference